Ash Jain

805 total citations
9 papers, 400 citations indexed

About

Ash Jain is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ash Jain has authored 9 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Surgery, 3 papers in Cardiology and Cardiovascular Medicine and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ash Jain's work include Peripheral Artery Disease Management (3 papers), Acute Ischemic Stroke Management (2 papers) and Coronary Interventions and Diagnostics (2 papers). Ash Jain is often cited by papers focused on Peripheral Artery Disease Management (3 papers), Acute Ischemic Stroke Management (2 papers) and Coronary Interventions and Diagnostics (2 papers). Ash Jain collaborates with scholars based in United States, Austria and New Zealand. Ash Jain's co-authors include Jeffrey J. Popma, Thaddeus R. Tolleson, Peter J. Fitzgerald, Donald E. Cutlip, Martin B. Leon, Laura Mauri, Eugenia Nikolsky, Ajay J. Kirtane, David E. Kandzari and Brent McLaurin and has published in prestigious journals such as Journal of the American College of Cardiology, The American Journal of Cardiology and Journal of Endovascular Therapy.

In The Last Decade

Ash Jain

8 papers receiving 383 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ash Jain United States	6	334	222	146	87	23	9	400
Satoshi Jissho Japan	11	92 0.3×	239 1.1×	65 0.4×	100 1.1×	13 0.6×	17	338
Rui Ribeiro Portugal	10	258 0.8×	85 0.4×	63 0.4×	7 0.1×	4 0.2×	33	348
Ebrahim Aghajani Norway	11	215 0.6×	82 0.4×	57 0.4×	14 0.2×	9 0.4×	16	328
Małgorzata Brzozowska-Kiszka Poland	6	127 0.4×	475 2.1×	67 0.5×	68 0.8×	11 0.5×	7	502
Ivana Nedeljković Serbia	13	150 0.4×	477 2.1×	43 0.3×	298 3.4×	44 1.9×	65	581
Thomas Meinertz Germany	9	98 0.3×	457 2.1×	64 0.4×	67 0.8×	14 0.6×	17	536
William S. Frankl United States	15	138 0.4×	405 1.8×	40 0.3×	46 0.5×	25 1.1×	47	521
Federica Guidetti Sweden	8	51 0.2×	168 0.8×	64 0.4×	24 0.3×	16 0.7×	17	233
J G Murtagh United Kingdom	12	107 0.3×	252 1.1×	43 0.3×	59 0.7×	5 0.2×	21	346
Paweł Ptaszyński Poland	11	92 0.3×	532 2.4×	27 0.2×	30 0.3×	11 0.5×	66	579

Countries citing papers authored by Ash Jain

Since Specialization

Citations

This map shows the geographic impact of Ash Jain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ash Jain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ash Jain more than expected).

Fields of papers citing papers by Ash Jain

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ash Jain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ash Jain. The network helps show where Ash Jain may publish in the future.

Co-authorship network of co-authors of Ash Jain

This figure shows the co-authorship network connecting the top 25 collaborators of Ash Jain. A scholar is included among the top collaborators of Ash Jain based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ash Jain. Ash Jain is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Krishnan, Prakash, Peter L. Faries, Khusrow Niazi, et al.. (2024). Stellarex Drug-Coated Balloon for the Treatment of Peripheral Artery Disease: Five-Year Results from the ILLUMENATE Pivotal Randomized Controlled Trial. The American Journal of Cardiology. 227. 83–90. 1 indexed citations

Jain, Ash & Matthew Kroenig. (2023). Ally Shoring: A New Tool of Economic Statecraft. Orbis. 67(1). 21–26. 2 indexed citations

Lyden, Sean P., Peter L. Faries, Khusrow Niazi, et al.. (2022). No Mortality Signal With Stellarex Low-Dose Paclitaxel DCB: ILLUMENATE Pivotal 4-Year Outcomes. Journal of Endovascular Therapy. 29(6). 929–936. 10 indexed citations

Hampson, Fen Osler, et al.. (2017). Strategy of “Constrainment”: Countering Russia’s Challenge to the Democratic Order.

Jain, Ash, et al.. (2014). Retrospective Study on National Institutes of Health Stroke Scale as a Predictor of Patient Recovery After Stroke. The Journal of Cardiovascular Nursing. 31(1). 69–72. 13 indexed citations

Laird, John R., Ash Jain, Thomas Zeller, et al.. (2014). Nitinol Stent Implantation in the Superficial Femoral Artery and Proximal Popliteal Artery: Twelve-Month Results From the Complete SE Multicenter Trial. Journal of Endovascular Therapy. 21(2). 202–212. 51 indexed citations

Yeung, Alan C., Martin B. Leon, Ash Jain, et al.. (2011). Clinical Evaluation of the Resolute Zotarolimus-Eluting Coronary Stent System in the Treatment of De Novo Lesions in Native Coronary Arteries. Journal of the American College of Cardiology. 57(17). 1778–1783. 102 indexed citations

Leon, Martin B., Laura Mauri, Jeffrey J. Popma, et al.. (2010). A Randomized Comparison of the Endeavor Zotarolimus-Eluting Stent Versus the TAXUS Paclitaxel-Eluting Stent in De Novo Native Coronary Lesions. Journal of the American College of Cardiology. 55(6). 543–554. 185 indexed citations

Yadav, Sunita, et al.. (1989). Irritable bowel syndrome: therapeutic evaluation of indigenous drugs.. PubMed. 90. 496–503. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact